Giovanni Grignani
Candiolo Cancer Institute - FPO IRCCS
144 papers found
Refreshing results…
Bempegaldesleukin plus nivolumab in first-line renal cell carcinoma: results from the PIVOT-02 study
Download from doi.orgMissing publications? Search for publications with a matching author name.